93 related articles for article (PubMed ID: 23178736)
41. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
42. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
Miuma S; Ichikawa T; Arima K; Takeshita S; Muraoka T; Matsuzaki T; Ootani M; Shibata H; Akiyama M; Ozawa E; Miyaaki H; Taura N; Takeshima F; Nakao K
J Cell Biochem; 2012 Oct; 113(10):3113-21. PubMed ID: 22581719
[TBL] [Abstract][Full Text] [Related]
43. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
44. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
45. Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma.
Zhu P; Lv J; Yang Z; Guo L; Zhang L; Li M; Han W; Chen X; Zhuang H; Lu F
Biochem Biophys Res Commun; 2014 Sep; 452(3):567-74. PubMed ID: 25172662
[TBL] [Abstract][Full Text] [Related]
46. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
47. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
48. αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
Huang XY; Ke AW; Shi GM; Zhang X; Zhang C; Shi YH; Wang XY; Ding ZB; Xiao YS; Yan J; Qiu SJ; Fan J; Zhou J
Hepatology; 2013 Jun; 57(6):2235-47. PubMed ID: 23316005
[TBL] [Abstract][Full Text] [Related]
49. [Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma].
Li X; Tang Z; Zhou G
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):12-4. PubMed ID: 10921046
[TBL] [Abstract][Full Text] [Related]
50. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
[TBL] [Abstract][Full Text] [Related]
51. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
Lin LI; Lee PH; Wu CM; Lin JK
Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
[TBL] [Abstract][Full Text] [Related]
52. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
54. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.
Wei L; Dai Y; Zhou Y; He Z; Yao J; Zhao L; Guo Q; Yang L
Cell Death Dis; 2017 Jul; 8(7):e2944. PubMed ID: 28726775
[TBL] [Abstract][Full Text] [Related]
55. Notch1 increases Snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells.
Kim HS; Jung G
Free Radic Res; 2014 Jul; 48(7):806-13. PubMed ID: 24684482
[TBL] [Abstract][Full Text] [Related]
56. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.
Björnson E; Mukhopadhyay B; Asplund A; Pristovsek N; Cinar R; Romeo S; Uhlen M; Kunos G; Nielsen J; Mardinoglu A
Cell Rep; 2015 Dec; 13(9):2014-26. PubMed ID: 26655911
[TBL] [Abstract][Full Text] [Related]
57. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
Dayton TL; Gocheva V; Miller KM; Israelsen WJ; Bhutkar A; Clish CB; Davidson SM; Luengo A; Bronson RT; Jacks T; Vander Heiden MG
Genes Dev; 2016 May; 30(9):1020-33. PubMed ID: 27125672
[TBL] [Abstract][Full Text] [Related]
58. MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing.
Yu L; Kim J; Jiang L; Feng B; Ying Y; Ji KY; Tang Q; Chen W; Mai T; Dou W; Zhou J; Xiang LY; He YF; Yang D; Li Q; Fu X; Xu Y
Nat Commun; 2020 Feb; 11(1):708. PubMed ID: 32024842
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
Balakrishnan K
Med Oncol; 2022 Oct; 39(12):247. PubMed ID: 36209296
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Lipid and Lipid Droplet Metabolism in Human HCC.
Berndt N; Eckstein J; Heucke N; Gajowski R; Stockmann M; Meierhofer D; Holzhütter HG
Cells; 2019 May; 8(5):. PubMed ID: 31137921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
